Literature DB >> 34150523

Effects of datumetine on hippocampal NMDAR activity.

Azeez Olakunle Ishola1,2, Aminu Imam1, Moyosore Salihu Ajao1.   

Abstract

The usage (abuse) of Datura metel is becoming increasingly worrisome among the Nigerian populace especially among the youth considering its side effects such as hallucination. This work was designed to identify the phytochemicals in datura plant that potentially interact with NMDAR as it affects the electrical and memory activities of the brain. Ligand-protein interaction was assessed using autodock vina to identify phytochemicals that can interact with NMDAR. Datumetine was found to have the best interaction fit with NMDAR at both allosteric and orthosteric binding sites. Furthermore, using electrophysiological, behavioural and western blotting techniques, it was observed that the administration of datumetine positively modulates the NMDAR current by prolonging burst duration and interspike interval, induces seizures in C57BL/6 mice. Acute exposure leads to memory deficit on NOR and Y-maze test while immunoblotting results showed increased expression of GluN1 and CamKIIα while pCamKIIα-T286, CREB and BDNF were downregulated. The results showed that the memory deficit seen in datura intoxication is possibly the effects of datumetine on NMDAR.
© 2021 The Authors.

Entities:  

Keywords:  Datumetine; Datura; Docking; Hippocampus; NMDAR

Year:  2021        PMID: 34150523      PMCID: PMC8190477          DOI: 10.1016/j.toxrep.2021.05.009

Source DB:  PubMed          Journal:  Toxicol Rep        ISSN: 2214-7500


  86 in total

1.  Activation of synaptic NMDA receptors induces membrane insertion of new AMPA receptors and LTP in cultured hippocampal neurons.

Authors:  W Lu; H Man; W Ju; W S Trimble; J F MacDonald; Y T Wang
Journal:  Neuron       Date:  2001-01       Impact factor: 17.173

Review 2.  LTP and LTD: an embarrassment of riches.

Authors:  Robert C Malenka; Mark F Bear
Journal:  Neuron       Date:  2004-09-30       Impact factor: 17.173

3.  Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk.

Authors:  Wendy Y Chen; Bernard Rosner; Susan E Hankinson; Graham A Colditz; Walter C Willett
Journal:  JAMA       Date:  2011-11-02       Impact factor: 56.272

Review 4.  Glutamate receptor ion channels: structure, regulation, and function.

Authors:  Stephen F Traynelis; Lonnie P Wollmuth; Chris J McBain; Frank S Menniti; Katie M Vance; Kevin K Ogden; Kasper B Hansen; Hongjie Yuan; Scott J Myers; Ray Dingledine
Journal:  Pharmacol Rev       Date:  2010-09       Impact factor: 25.468

Review 5.  Ca(2+)-activated K+ currents in neurones: types, physiological roles and modulation.

Authors:  P Sah
Journal:  Trends Neurosci       Date:  1996-04       Impact factor: 13.837

6.  NMDA receptor signaling: death or survival?

Authors:  Tong Luo; Wei-Hua Wu; Bo-Shiun Chen
Journal:  Front Biol (Beijing)       Date:  2011-10-20

7.  Repeated restraint stress alters hippocampal glutamate uptake and release in the rat.

Authors:  Fernanda Urruth Fontella; Deusa Aparecida Vendite; Angela Sampaio Tabajara; Lisiane O Porciúncula; Iraci Lucena da Silva Torres; Flúvia Melina Jardim; Lúcia Martini; Diogo O Souza; Carlos Alexandre Netto; Carla Dalmaz
Journal:  Neurochem Res       Date:  2004-09       Impact factor: 3.996

8.  Recovery of hippocampal cell proliferation and BDNF levels, both of which are reduced by repeated restraint stress, is accelerated by chronic venlafaxine.

Authors:  H Xu; C Luo; J S Richardson; X M Li
Journal:  Pharmacogenomics J       Date:  2004       Impact factor: 3.550

Review 9.  Synaptic versus extrasynaptic NMDA receptor signalling: implications for neurodegenerative disorders.

Authors:  Giles E Hardingham; Hilmar Bading
Journal:  Nat Rev Neurosci       Date:  2010-09-15       Impact factor: 34.870

10.  Calcium input frequency, duration and amplitude differentially modulate the relative activation of calcineurin and CaMKII.

Authors:  Lu Li; Melanie I Stefan; Nicolas Le Novère
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.